HomeInsightsPE

Nectar Lifescience Ltd PE Ratio

Nectar Lifescience Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

96.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Nectar Lifescience Ltd

NSE: NECLIFE

PE

71.3

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Nectar Lifescience Ltd is 71.3 as of 22 Nov 12:37 PM .
  • The P/E Ratio of Nectar Lifescience Ltd changed from 8.1 on March 2019 to 136.9 on March 2024 . This represents a CAGR of 60.20% over 6 years.
  • The Latest Trading Price of Nectar Lifescience Ltd is ₹ 34.15 as of 22 Nov 12:16 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Nectar Lifescience Ltd

No data available

Company Fundamentals for Nectar Lifescience Ltd

No data available

Image

Nectar Lifescience Ltd

NSE: NECLIFE

Share Price

₹ 34.15

-0.05 (-0.15%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Nectar Lifescience Ltd

1M

1Y

3Y

5Y

Monitoring Nectar Lifescience Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 202434.2
19 Nov 202434.89
18 Nov 202435.6
14 Nov 202436
13 Nov 202435.4
12 Nov 202435.28
11 Nov 202436
08 Nov 202436.6
07 Nov 202437.34
06 Nov 202438.1

SWOT Analysis Of Nectar Lifescience Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Nectar Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Nectar Lifescience Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Nectar Lifescience Ltd71766
Sun Pharmaceuticals Industries Ltd384,26,518
Divis Laboratories Ltd861,58,636
Cipla Ltd251,18,365
Torrent Pharmaceuticals Ltd601,05,067
Mankind Pharma Ltd481,02,273

Key Valuation Metric of Nectar Lifescience Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Nectar Lifescience Ltd

No data available

* All values are in crore

Historical Revenue of Nectar Lifescience Ltd

No data available

* All values are in crore

Historical EBITDA of Nectar Lifescience Ltd

No data available

* All values are in crore

Historical Net Profit of Nectar Lifescience Ltd

No data available

* All values are in crore

Historical Dividend Payout of Nectar Lifescience Ltd

No data available

* All values are in %

About Nectar Lifescience Ltd

  • Nectar Lifesciences Ltd (NLL or NECLIFE) is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
  • The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsules at their facilities spread across three Indian states of Punjab, Himachal Pradesh and Jammu.
  • They have developed sustainable production systems to manufacture high quality intermediates and APIs to meet the diverse requirements of their customer base in India and over 90 countries worldwide. The company's business operations are primarily concentrated on manufacturing and marketing of oral and sterile cephalosporins, phytochemicals and allied products.
  • They manufacture and sell a range of cephalosporins and phytochemicals.

Nectar Lifescience Ltd News Hub

News

Nectar Lifescience to conduct AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

2024-08-20 00:00:00

News

Nectar Lifescience to convene AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

2024-08-20 00:00:00

News

Nectar Lifescience consolidated net profit rises 63.19% in the June 2024 quarter

Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 20...

Read more

2024-08-14 00:00:00

News

Nectar Lifescience to conduct board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 Augu...

Read more

2024-08-06 00:00:00

News

Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

2024-11-04 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Nectar Lifescience Ltd

What is the current PE Ratio of Nectar Lifescience Ltd?

The Current PE Ratio of Nectar Lifescience Ltd is 71.25 as on 22 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Nov 2024.

What was the PE Ratio of Nectar Lifescience Ltd last year?

The PE Ratio of Nectar Lifescience Ltd was 0.0 last year, now the PE ratio is 71.25, showing a year-on-year growth of -%.

What does the PE Ratio of Nectar Lifescience Ltd indicate about its stock?

The PE Ratio of Nectar Lifescience Ltd is 71.25. This ratio indicates that investors are willing to pay 71.25 times the earnings per share for each share of Nectar Lifescience Ltd.

What is the PE Ratio Growth of Nectar Lifescience Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Nectar Lifescience Ltd grew by -% whereas, the EPS ratio grew by 92.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*